by Staff Writer February 13, 2026 in Company updates & acquisitions, Conferences, Events, Eye disease, International, Light-based therapy, Myopia, Myopia interventions, News, Ophthalmic equipment & diagnostics, Ophthalmic organisations, Ophthalmic Treatments, Repeated low-level red-light therapy, Report, Research

From Innovation To Standardisation：The Official Launch of the International Red Light Ophthalmic Society(IRLOS) As global adoption of Red Light Therapy accelerates, the need for independent scientific oversight,standardised protocols,and rigorous safety monitoring has never been greater.

We’re incredibly proud to see our study collaborators in Portugal, Prof José Salgado-Borges, Prof Catarina Mateus and Dr Carla Lance, publish an insightful article in OftalPro on the integration of repeated low-level red light (RLRL) therapy into their pan-European multi-centre study on myopia management.

We are thrilled to announce the publication of the first 12-month RCT of RLRL in a Caucasian population, with a RCT comparing the combination use of RLRL and orthokeratology to orthokeratology alone, published in the British Journal of Ophthalmology.

A groundbreaking new multicentre real-world cohort study published in The British Journal of Opthalmology has evaluated the long-term efficacy and safety of repeated low-level red-light (RLRL) treatment in myopic children and adolescents for periods of up to and over 3 years. Importantly, this study included ffERG as a more sensitive marker of retinal function.

“We’re incredibly proud to see our study collaborators in Portugal, Prof José Salgado-Borges, Prof Catarina Mateus and Dr Carla Lance, publish an insightful article in OftalPro on the integration of repeated low-level red light (RLRL) therapy into their pan-European multi-centre study on myopia management. ”